» Articles » PMID: 29474424

The Longitudinal Association Between Changes in Lung Function and Changes in Abdominal Visceral Obesity in Korean Non-smokers

Overview
Journal PLoS One
Date 2018 Feb 24
PMID 29474424
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity, particularly abdominal obesity, might be related to decreased lung function. We aimed to investigate whether obesity indices are associated with forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) in asymptomatic non-smokers through a longitudinal cohort study. The clinical records of 1,145 subjects (428 males, mean age 52.3 years) who underwent a comprehensive health evaluation, including spirometry and abdominal fat computed tomography, at least twice between 2007 and 2014 were retrospectively reviewed and analysed. The mean follow-up period was 1,105 days (over 3.0 years). The baseline total adipose tissue (TAT) and visceral adipose tissue (VAT) were inversely associated with both FEV1 and FVC (P < 0.05). The longitudinal study found that increasing TAT and VAT were significantly related to decreasing FEV1 and FVC, whereas decreasing TAT and VAT were related to increasing FEV1 and FVC in both males and females (P < 0.05). The strength and consistency of these associations were clearer in males than in females. However, no significant relationship was found between changes in subcutaneous adipose tissue and changes in lung function. In Korean non-smokers, longitudinal changes in abdominal visceral fat were found to be inversely related to changes in lung function over a mean period of three years. These results suggest that decreasing abdominal visceral obesity could increase lung function despite ageing.

Citing Articles

The association between abdominal obesity and pulmonary function trajectories among patients with COPD.

Wang C, Wang Y, Zeng W, Chen H, Pan M, Shang S Sci Rep. 2025; 15(1):7889.

PMID: 40050433 PMC: 11885562. DOI: 10.1038/s41598-025-92982-x.


Association Between Weight-Adjusted Waist Index and Emphysema in Adults in the United States: A Cross-Sectional Study Involving 44,949 Participants.

Cheng H, Yang Z, Guo J, Zu Y, Li F, Zhao B Adv Respir Med. 2024; 92(6):472-484.

PMID: 39584854 PMC: 11586996. DOI: 10.3390/arm92060043.


Risk estimation of cardiovascular diseases using the World Health Organization/International Society of Hypertension risk prediction charts in the Azar cohort population: Cross-sectional study.

Faramarzi E, Somi M, Ostadrahimi A, Molani-Gol R, Khamnian Z, Ghaffari S J Cardiovasc Thorac Res. 2024; 16(2):88-96.

PMID: 39253346 PMC: 11380746. DOI: 10.34172/jcvtr.32906.


Longitudinal effects of obesity on pulmonary function in obese children and adolescents.

Charoensittisup P, Udomittipong K, Mahoran K, Palamit A Pediatr Res. 2024; .

PMID: 39244608 DOI: 10.1038/s41390-024-03544-2.


Assessment of Behavioral Risk Factors in Chronic Obstructive Airway Diseases of the Lung Associated with Metabolic Syndrome.

Mihai A, Mititelu M, Matei M, Lupu E, Streba L, Vladu I J Clin Med. 2024; 13(4).

PMID: 38398353 PMC: 10889340. DOI: 10.3390/jcm13041037.


References
1.
Lim S, Rhee E, Sung K . Metabolic syndrome, insulin resistance and systemic inflammation as risk factors for reduced lung function in Korean nonsmoking males. J Korean Med Sci. 2010; 25(10):1480-6. PMC: 2946659. DOI: 10.3346/jkms.2010.25.10.1480. View

2.
Thijs W, Alizadeh Dehnavi R, Hiemstra P, de Roos A, Melissant C, Janssen K . Association of lung function measurements and visceral fat in men with metabolic syndrome. Respir Med. 2013; 108(2):351-7. DOI: 10.1016/j.rmed.2013.10.003. View

3.
Fontana L, Eagon J, Trujillo M, Scherer P, Klein S . Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007; 56(4):1010-3. DOI: 10.2337/db06-1656. View

4.
Chen Y, Breithaupt K, Muhajarine N . Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related risk factors. J Clin Epidemiol. 2000; 53(7):755-61. DOI: 10.1016/s0895-4356(99)00211-5. View

5.
Gurka M, Vishnu A, Santen R, DeBoer M . Progression of Metabolic Syndrome Severity During the Menopausal Transition. J Am Heart Assoc. 2016; 5(8). PMC: 5015287. DOI: 10.1161/JAHA.116.003609. View